Brought to you by 
Adimab generates antibodies for Roche
17 Jun 2009
Executive Summary
After announcing at the recent BIO meeting that it would be penning alliances in the near future to validate its platform, Adimab has come through on its promise. In one of two Big Pharma deals announced concurrently, the start-up has agreed to generate fully human antibodies for Roche. (Adimab signed the other alliance with Merck.)
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Adimab generates antibodies for Roche
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice